Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
What the Research Says BPC-157: Evidence Overview What the Research Supports (Animal Models) The majority of BPC-157 research has been conducted in rodent models and has demonstrated: Accelerated healing of tendon, ligament, and muscle injuries Gastroprotective effects against NSAID-induced ulcers and inflammatory bowel lesions Neuroprotection in models of traumatic brain injury and peripheral nerve damage Systemic anti-inflammatory activity Bone healing support and osteoblast activity enhancement The animal research for BPC-157 is genuinely compelling in breadth
Glutathione deficiency increases oxidative stress
She is a recipient of the Academy's Media Excellence Award and is a contributor to Communicating Nutrition: The Authoritative Guide, the Academy's book on nutrition communications
The drug is called retatrutide and is not yet available publicly, and Eli Lilly has said that the experimental medication is only available as part of an official clinical trial
